英文名稱 | Azeliragon (TTP488) |
---|---|
中文名稱 | 阿齊瑞格 |
CAS號(hào) | 603148-36-3 |
分子式 | C32H38ClN3O2 |
分子量 | 532.13 |
外觀 | White to off-white powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
---|---|---|---|---|
5 mg | In-stock | ¥1000.00 | 登錄后可見(jiàn) | |
10 mg | In-stock | ¥1660.00 | 登錄后可見(jiàn) | |
20 mg | In-stock | ¥2800.00 | 登錄后可見(jiàn) |
英文名稱 | Azeliragon (TTP488) |
---|---|
中文名稱 | 阿齊瑞格 |
CAS號(hào) | 603148-36-3 |
分子式 | C32H38ClN3O2 |
分子量 | 532.13 |
外觀 | White to off-white powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Azeliragon (TTP488, PF-04494700) is an orally bioavailable small molecule that inhibits the receptor for advanced glycation endproducts (RAGE), which is an immunoglobulin-like cell surface receptor overexpressed in brain tissues of patients with AD.